Levothyroxine, which is the third most popular drug in the US and the main drug used to treat primary hypothyroidism, also possesses clinically significant interactions with food, beverages, and supplements that can change the safety and efficacy of thyroid-hormone replacement therapies. This review article from Pharmaceuticals reviews 925 hypothyroid patients that highlighted “disturbing” lifestyle and diet patterns.

A single, unifying etiology for FMD is not yet known, and this article from Practical Neurology characterizes diagnosing the disorder as “a process involving a careful history and examination for positive signs to rule in the diagnosis, while considering the differential diagnoses of functional presentations.”

With fast symptom relief and reinforcing effects, benzodiazepines were once the gold standard for treating insomnia and anxiety. As opioids dominate headlines along with the public health crisis of drug overdose deaths, is it time to reconsider benzodiazepines as a course of treatment?

To date, no Cdk5 inhibitor has been approved to treat any neuropsychiatric or degenerative diseases due to challenges at the blood-brain barrier. James Bibb, Ph.D., and colleagues seek to change that notion with their brain-permeable compound, 25-106.

A fact-filled video program all about ALZ-801 (valiltramiprosate), an oral medication with a novel mode of action that aims to slow or stop Alzheimer’s disease altogether.

Hear, watch, or read the top-line observations from a Harris Poll that included more than 360 patients and 120 caregivers on the impact of symptomatic neurogenic orthostatic hypotension (nOH). Suffice, many described severe limitations to their ability to perform activities that are necessary for day-to-day living.